Oragenics appoints John Spencer as CFO, holds annual meeting with mixed votes

Oragenics, Inc., incorporated in Florida and headquartered in Lakewood Ranch, Florida¹, disclosed in an 8-K that effective July 1, 2026, the Board of Directors appointed John Spencer, the Company's Senior Controller, to serve as Chief Financial Officer, and the Company entered into an Executive Employment Agreement with him¹. The Employment Agreement provides for base compensation of $200,000¹, and contains customary confidentiality, non-competition and non-solicitation provisions¹. In connection with the appointment, Spencer received an option award equal to $25,000, with an exercise price equal to the closing price of the Company's common stock on the NYSE American immediately prior to the grant date¹.

Spencer, age 32, joined the Company in April 2025 as Senior Controller and has led its finance and accounting organization, including SEC reporting, financial planning and analysis, treasury, budgeting, internal controls, audit coordination, and capital markets support¹. He previously served as Vice President of Finance at Trxade Health, Inc., began his career at PricewaterhouseCoopers LLP, and is a Certified Public Accountant in Florida with a Master of Accountancy and Bachelor of Science in Accounting from the University of South Florida¹.

The filing also covered the company's annual meeting. The Annual Meeting was held on June 29, 2026¹. Six directors, including Charles Pope, Frederick Telling, Robert Koski, Alan Dunton, John Gandolfo and Natasha Giordano, were re-elected¹. Shareholders also passed a non-binding vote on executive pay, authorized the Board to enact a reverse stock split at a ratio between one-for-two and one-for-fifty within one year of approval¹, and ratified Cherry Bekaert LLP as independent auditor for fiscal year 2026¹.